Negotiamini Media
Truth is Powerful

Panelists discuss present & future reimbursement mechanisms for AI health care products


At our recent Health Care AI Law and Policy Summit , Hogan Lovells partner Stuart Langbein moderated a panel discussion on AI policy and reimbursement issues. Joined by representatives from CMS Medicare Administrative Contractor (MAC) Noridian Healthcare Solutions, the AI Healthcare Coalition, Digital Diagnostics, and Tempus, the group’s discussion centered around Medicare’s challenges in providing proper payment to AI innovators within existing reimbursement frameworks. The panel considered issues related to coding, pilot payment programs, Medicaid, ethical guardrails, and the amount of information that regulators should require in medical product submissions for new technologies. We have summarized this discussion below, and the opinions expressed were those of the individuals and not those of their organizations. AI development seen outpacing reimbursement mechanisms

Teeing up the Summit’s discussion over the need to define categories within AI for reimbursement, Michael Abramoff, MD, PhD, founder and executive chairman at Digital Diagnostics, an autonomous AI company, and Chair of the AI Healthcare Coalition, shared concerns over how to fit the technology of AI into clinical practice, and explained how ethics have been leveraged to create AI reimbursement frameworks, providing for adequate guardrails related to patient benefit, mitigation of racial, ethnic and other bias, and cost, […]

Click here to view original web page at


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More